IBDEI1ZQ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33777,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,33777,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,33777,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,33778,0)
 ;;=Q61.2^^131^1676^79
 ;;^UTILITY(U,$J,358.3,33778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33778,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,33778,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,33778,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,33779,0)
 ;;=N41.1^^131^1676^83
 ;;^UTILITY(U,$J,358.3,33779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33779,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,33779,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,33779,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,33780,0)
 ;;=N11.9^^131^1676^91
 ;;^UTILITY(U,$J,358.3,33780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33780,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,33780,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,33780,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,33781,0)
 ;;=N20.9^^131^1676^102
 ;;^UTILITY(U,$J,358.3,33781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33781,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,33781,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,33781,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,33782,0)
 ;;=R51.^^131^1677^2
 ;;^UTILITY(U,$J,358.3,33782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33782,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,33782,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,33782,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,33783,0)
 ;;=G44.1^^131^1677^9
 ;;^UTILITY(U,$J,358.3,33783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33783,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,33783,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,33783,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,33784,0)
 ;;=G43.909^^131^1677^5
 ;;^UTILITY(U,$J,358.3,33784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33784,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,33784,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,33784,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,33785,0)
 ;;=G44.009^^131^1677^1
 ;;^UTILITY(U,$J,358.3,33785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33785,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,33785,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,33785,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,33786,0)
 ;;=G44.40^^131^1677^4
 ;;^UTILITY(U,$J,358.3,33786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33786,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,33786,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,33786,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,33787,0)
 ;;=G44.89^^131^1677^3
 ;;^UTILITY(U,$J,358.3,33787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33787,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,33787,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,33787,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,33788,0)
 ;;=G44.84^^131^1677^7
 ;;^UTILITY(U,$J,358.3,33788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33788,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,33788,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,33788,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,33789,0)
 ;;=G44.301^^131^1677^6
 ;;^UTILITY(U,$J,358.3,33789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33789,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,33789,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,33789,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,33790,0)
 ;;=G44.209^^131^1677^8
 ;;^UTILITY(U,$J,358.3,33790,1,0)
 ;;=^358.31IA^4^2
